NEM
50
2
AON
34
2
PVH
62
2
SJM
21
-3
DD
55
2
FOXA
57
-2
TROW
54
-2
UPS
51
-4
AME
54
-5
ISRG
71
3
RF
48
-3
C
60
-2
URI
45
-4
HAL
41
2
KLAC
57
3
GOOG
87
6
MRK
25
-5
NWL
66
-3
STZ
55
-3
AMP
54
2
NEM
50
2
AON
34
2
PVH
62
2
SJM
21
-3
DD
55
2
FOXA
57
-2
TROW
54
-2
UPS
51
-4
AME
54
-5
ISRG
71
3
RF
48
-3
C
60
-2
URI
45
-4
HAL
41
2
KLAC
57
3
GOOG
87
6
MRK
25
-5
NWL
66
-3
STZ
55
-3
AMP
54
2
Financhill
Back

icad Vs. Perspective Therapeutics Industry Stock Comparison

Sell
50

ICAD
icad

Last Price:
2.04
Seasonality Move:
15.17%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.48
Seasonality Move:
22.12%
Sell
50
icad (ICAD) is a Sell

Is icad a Buy, Sell or Hold?

  • The current icad [ICAD] share price is $1.97. The Score for ICAD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ICAD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.45. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ICAD Stock Price Chart

What is icad's stock price today?

  • The icad share price today is $1.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ICAD is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

ICAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 60.76 Buy
Chaikin Money Flow: -123022 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.57 - 2.03) Buy
Bollinger Bands (100): (1.39 - 1.85) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 21.95 Sell
Chaikin Money Flow: -1254860 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.15 - 9.41) Sell
Bollinger Bands (100): (7.96 - 15.18) Sell

ICAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.79 Buy
20-day SMA: 1.73 Buy
50-day SMA: 1.76 Buy
200-day SMA: 1.58 Buy
8-day EMA: 1.82 Buy
20-day EMA: 1.78 Buy
50-day EMA: 1.74 Buy
200-day EMA: 1.64 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.78 Sell
20-day SMA: 4.99 Sell
50-day SMA: 9.38 Sell
200-day SMA: 12.42 Sell
8-day EMA: 3.85 Sell
20-day EMA: 5.31 Sell
50-day EMA: 8.21 Sell
200-day EMA: 10.51 Sell

icad Earnings Growth & ICAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.02 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

icad Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):